Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scottish funding to develop single blood test:

This article was originally published in Clinica

Executive Summary

The UK's University of Edinburgh has received funding to develop a single blood screening test, under the Scottish Executive's Proof of Concept Fund. The award announced today (February 28 2003) will be used to develop a system that researchers believe can simplify the process involved in processing the estimated 25 million blood donations screened worldwide every year. These currently undergo multiple testing before they are deemed safe; a single test would result in greater efficiency and, therefore, significant cost savings. The research will involve the Scottish National Blood Transfusion Service and the Scottish Centre for Genomic Technology and Informatics. The £33m ($52m) Proof of Concept Fund has financed 118 "leading-edge technology" projects in academic institutions, with the aim of promoting their commercial development, since it was set up in 1999.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061334

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel